Nodysis Pharma Private Limited
About Nodysis Pharma Private Limited
Data last updated:
Nodysis Pharma Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 09 December 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51397OR2002PTC006992. Its GSTIN is 21AABCN7648H1ZI (Odisha).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.35 Cr. It is led by directors including Sanat Kumar Meher (Managing Director) and Tushar Kanti Pattnaik.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Gn 27 Ganesh Nagar Gandhamunda Khandagiri, Bhubaneswar, Odisha, India – 751030.
As per the financials filed for FY 2023, the company reported a revenue of ₹8.72 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹26.74 Lakh (net margin -306.5%) and EBITDA of -₹25.76 Lakh (EBITDA margin -295.4%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 43% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹15.28 Lakh and satisfied charges of ₹1.57 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGn 27 Ganesh Nagar Gandhamunda Khandagiri, Bhubaneswar, Odisha, India – 751030
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nodysis Pharma Private Limited
The main business activity of Nodysis Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nodysis Pharma Private Limited FY 2023 filings available
Nodysis Pharma Private Limited reported revenue of ₹8.72 Lakh (down 84% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Nodysis Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 43% over five years, including a 84% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nodysis Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹25.76 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹26.74 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nodysis Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -295.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -306.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nodysis Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nodysis Pharma Private Limited
Nodysis Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brivan Biotech Private Limited | ₹8.78 Lakh (FY 2024) | •••• | •••• | 32.0% | •••• | Ranip, Gujarat, India |
| Hitech Herbal Sanitation Private Limited | ₹8.77 Lakh (FY 2024) | •••• | •••• | -78.0% | •••• | Bhubaneswar, Odisha, India |
| Bioviq Life Science Private Limited | ₹8.74 Lakh (FY 2023) | •••• | •••• | 182.0% | •••• | Karnataka, India |
| Mosaica Ceracon Private Limited | ₹8.74 Lakh (FY 2024) | •••• | •••• | 2214.0% | •••• | Nandesari, Gujarat, India |
| Ashwamedham Ayurveda Private Limited | ₹8.74 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Mehsana, Gujarat, India |
| Nodysis Pharma Private Limited this company | ₹8.72 Lakh (FY 2023) | •••• | •••• | -84.0% | •••• | Bhubaneswar, Odisha, India |
| Fiducia Botanical Skincare Private Limited | ₹8.72 Lakh (FY 2025) | •••• | •••• | 333.0% | •••• | Raipur, Chhattisgarh, India |
| Essence Pharmaceuticals Private Limited | ₹8.71 Lakh (FY 2016) | •••• | •••• | -53.0% | •••• | New Delhi, Delhi, India |
| Dinesh Pharmaceutical Pvt Ltd | ₹8.7 Lakh (FY 2020) | •••• | •••• | 29900.0% | •••• | Vadodara, Gujarat, India |
| MBM Pharmaceuticals Private Limited | ₹8.7 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Akola, Maharashtra, India |
| Domcain Pharmaceuticals Private Limited | ₹8.69 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Nodysis Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nodysis Pharma Private Limited
Nodysis Pharma Private Limited is audited by PANIGRAHI&CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PANIGRAHI&CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nodysis Pharma Private Limited
Nodysis Pharma has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanat Kumar Meher | Managing Director | 09 Dec 2002 | 23 Years 10 Months | Current |
| Tushar Kanti Pattnaik | Director | 24 Oct 2011 | 14 Years 11 Months | Current |
| Sushil Kumar Sahu | Director | 24 Oct 2011 | 14 Years 11 Months | Current |
| Prasanta Kumar Meher | Director | 24 Oct 2011 | 14 Years 11 Months | Current |
| Sujit Kumar Das Also directs: Nap Pharma Private Limited | Director | 24 Oct 2011 | 14 Years 11 Months | Current |
| Nilay Kumar Ghosh Also directs: Nap Pharma Private Limited | Director | 24 Oct 2011 | 14 Years 11 Months | Current |
Ownership and Shareholding of Nodysis Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nodysis Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2007 | Icici Bank Limited | ₹15.28 Lakh | Open |
| 26 Nov 2011 | Reliance Capital Ltd | ₹24.08 Lakh | Satisfied |
| 31 Jul 2008 | Reliance Capital Ltd | ₹29.2 Lakh | Satisfied |
| 28 Jul 2007 | Icici Bank Limited | ₹13.5 Lakh | Satisfied |
| 28 Jul 2007 | Icici Bank Limited | ₹15.28 Lakh | Satisfied |
Total charge records: 6 View all charges
Legal Cases of Nodysis Pharma Private Limited
Nodysis Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Tata Capital Financial Services Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Nodysis Pharma Private Limited
Nodysis Pharma Private Limited has a workforce of 9 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nodysis Pharma Private Limited
Nodysis Pharma Private Limited has 7 board changes on record since 2002: 6 appointments and 1 cessation. The latest: Shrikrushna Sahaya Behera ceased to be Whole-Time Director on 01 Mar 2019.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nodysis Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nodysis Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nodysis Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nodysis Pharma Private Limited
Nodysis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AABCN7648H1ZI | Odisha | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nodysis Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nodysis Pharma Private Limited
Nodysis Pharma is an active private limited company based in Bhubaneswar, Odisha, India. The company works in wholesale, within the trading industry. It was incorporated on 09 December 2002 (24+ years old) and is registered under CIN U51397OR2002PTC006992.
Nodysis Pharma reported revenue of ₹8.72 Lakh for FY 2023 (down 84% YoY).
Nodysis Pharma has 6 current directors:
- Sanat Kumar Meher - Managing Director
- Tushar Kanti Pattnaik - Director
- Sushil Kumar Sahu - Director
- Prasanta Kumar Meher - Director
- Sujit Kumar Das - Director
- Nilay Kumar Ghosh - Director
Nodysis Pharma reported a net loss of ₹26.74 Lakh (net margin -306.5%) and EBITDA of -₹25.76 Lakh (EBITDA margin -295.4%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nodysis Pharma is -59% over three years and -43% over five years. In the latest year (FY 2023) revenue fell 84%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nodysis Pharma is 21AABCN7648H1ZI, registered in Odisha.
The CIN (Corporate Identification Number) of Nodysis Pharma is U51397OR2002PTC006992. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nodysis Pharma has 1 court case on record: 1 filed against it.
Nodysis Pharma was incorporated on 09 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Nodysis Pharma by revenue are Brivan Biotech Private Limited, Hitech Herbal Sanitation Private Limited, Bioviq Life Science Private Limited, Mosaica Ceracon Private Limited, Ashwamedham Ayurveda Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shrikrushna Sahaya Behera ceased to be Whole-Time Director on 01 Mar 2019. Nilay Kumar Ghosh was appointed as Director on 24 Oct 2011. Prasanta Kumar Meher was appointed as Director on 24 Oct 2011. Nodysis Pharma has 7 board changes on record in total.